Molecular Analysis for Precision Oncology Congress 2026 will convene on 10 and 11 September 2026 in London, bringing together specialists in oncology, molecular diagnostics and precision medicine.
Event Details
Organisers include Cancer Research UK, the European Society for Medical Oncology and Unicancer. The congress will be held in London, United Kingdom, and is designed as a platform for sharing the latest cancer research advances.
The two‑day agenda features keynote talks, panel discussions and networking sessions aimed at translating molecular insights into patient care. Keynote sessions will showcase leading experts who will present cutting‑edge data and strategic perspectives.
According to the schedule, attendees will examine the changing field of precision oncology and its worldwide impact. Attendees will examine how precision oncology reshapes treatment pathways across diverse health systems worldwide.
The venue will host a poster area as well as an e‑poster gallery for digital presentations. All presented abstracts will later be accessible through the OncologyPRO portal, ensuring lasting visibility.
Industry partners will present in a dedicated exhibition space, offering a chance to see the latest tools and therapies.
The gathering builds on momentum from earlier editions, hoping to strengthen cross‑disciplinary links.
Registration and Participation
To register, participants need an ESMO account, a completed form and payment in euros.
Active ESMO membership is required ten working days before registration to qualify for the reduced member fee.
Read Also: Uzbekistan pharmaceutical market is highly dynamic
Details on eligibility and benefits are available on the ESMO membership page, and applicants must also provide current contact information.
Registered delegates receive access to scientific sessions, the poster zones, industry satellite symposia and post‑event resources on OncologyPRO. This includes participation in scientific and educational sessions, networking opportunities, and interaction with industry partners.
The platform will host recordings and abstracts after the meeting concludes, allowing later review. Resources will be available post‑event on OncologyPRO.
Fees vary by individual or group registration, with deadlines outlined in the official notice.
Payment must reach the ESMO Congress Secretariat by the stated dates, and confirmation emails are sent once processing is complete. One completed registration per participant is required for the payment to be processed.
Scientific Focus
The program highlights advances in molecular characterisation, including extrachromosomal DNA biology.
It also covers technologies for cancer interception, early detection and profiling, such as liquid biopsy and multi‑omic biomarkers.
Mechanisms of tumour progression, immune activity and metastatic spread will be discussed, alongside breakthroughs in epigenetic regulation.
Learning objectives stress understanding of emerging approaches, recognising successes and pinpointing obstacles in clinical research.
